article thumbnail

Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes

Cardiovascular Diabetology

A key driver of the observed increase in direct costs was prescription drug costs, which increased by 37% among all individuals with ASCVD. Individuals with diabetes had a 1.5-fold fold higher mean expenditure that those without diabetes.

article thumbnail

How to Get Free or Lower Cost Insulin for Your Medicare and Non-Medicare Patients: Shattering Barriers to Insulin Access

Cardiometabolic Health Congress

Part D Insulin Costs The Medicare drug plan can’t charge beneficiaries more than $35 for a one-month supply of each Part D-covered insulin, and they don’t have to pay a deductible. If Medicare beneficiaries receive a 3-month supply of insulin, their costs cannot exceed $105 ($35 for each month’s supply).

article thumbnail

The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care

Cardiometabolic Health Congress

Novo Nordisk lowered list prices on several of its insulin products by up to 75% and continues to run programs that cap insulin costs at $25-35 for eligible patients. However, increasing government and activist pressure has forced manufacturers to lower insulin costs.